- CEO
- Rukkagee Kanchanapitak
- Full Time Employees
- 1,909
- Sector
- Health services
- Industry
- Medical/Nursing services
- Address
- 436 Ramkhamhaeng Road Bangkok BM Thailand 10240
- IPO Date
- Sep 13, 1991
- Business
- Ramkhamhaeng Hospital Public Company Limited is a Thailand-based healthcare service provider operating primarily in the hospital and related healthcare segments. Founded in 1976 and headquartered in Bangkok, the company operates large private hospitals, including its flagship Ramkhamhaeng Hospital, and a network of seven sister hospitals. It offers comprehensive medical services across all specialties and subspecialties, supported by experienced physicians, medical professionals, and state-of-the-art medical equipment. Key services include general medical treatment for inpatients and outpatients under various government welfare programs such as the Social Security Scheme and the National Health Security Office. The company has established Centers of Excellence such as a 24-hour Heart Center, Laparoscopic Surgery Center (RAM Pituitary Center), Neurology, Diabetic Foot Center with hyperbaric oxygen therapy, Ear Nose and Throat Surgery Center, and a Health and Weight Center offering personalized weight-loss programs and minimally invasive surgery. It also provides advanced cancer treatment including radiotherapy, chemotherapy, and precise radiotherapy planning, aiming to become a comprehensive cancer treatment center in eastern Thailand. Beyond hospital operations, Ramkhamhaeng Hospital also engages in the sale and repair of medical equipment and instruments, property development, training services, and software business operations.
Recent major developments include the strategic acquisition of a 99.999% stake in M.I. Calibration System Co., Ltd. for THB 500 million to support medical equipment calibration services. The hospital group has been expanding its patient base and improving operational efficiency with a focus on service quality enhancements. The company is also extending its facilities through renovation and new construction to accommodate growth, while pursuing portfolio asset management through acquisitions and divestitures of non-core assets. Financially, the group reported a 2% increase in operating revenue toward the end of 2024, driven by a rise in healthcare revenue, and expects further revenue growth in 2025. It continues to invest in additional medical technology, including purchasing new radiotherapy machines, to meet rising patient demand from general and government welfare programs. The hospital’s strategy is focused on extensive expansion within Bangkok and other provinces to lead the largest hospital network in Thailand with international standards of care. The company’s comprehensive healthcare offerings and recent strategic acquisitions position it for continued growth in the private hospital market in Thailand.